Role of Monoclonal Antibodies in the Treatment of Asthma

BACKGROUND: Patients with severe refractory asthma represent a small subset of the asthmatic population (between 5% and 10% of all patients) but are the greatest burden to the health care system. New treatment approaches developed to manage some of the phenotypes of severe refractory asthma have inc...

Full description

Saved in:
Bibliographic Details
Main Author: Paul M O’Byrne
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2013/183948
Tags: Add Tag
No Tags, Be the first to tag this record!